ChemGenex to follow potential regulatory pathway for Omapro
Saturday, July 17, 2010 16:00 IST Melbourne, Australia
ChemGenex Pharmaceuticals Limited has agreed with the US Food and Drug Administration (FDA) a potential regulatory path to progress Omapro (omacetaxine mepesuccinate)